nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—Irinotecan—stomach cancer	0.12	0.24	CbGbCtD
Riluzole—ABCG2—Fluorouracil—stomach cancer	0.115	0.23	CbGbCtD
Riluzole—ABCG2—Docetaxel—stomach cancer	0.0879	0.176	CbGbCtD
Riluzole—ABCG2—Doxorubicin—stomach cancer	0.0655	0.131	CbGbCtD
Riluzole—ABCG2—Methotrexate—stomach cancer	0.0635	0.127	CbGbCtD
Riluzole—CYP1A2—Fluorouracil—stomach cancer	0.0475	0.095	CbGbCtD
Riluzole—SLC7A11—smooth muscle tissue—stomach cancer	0.000223	0.145	CbGeAlD
Riluzole—SLC7A11—pancreas—stomach cancer	0.000206	0.134	CbGeAlD
Riluzole—SLC7A11—digestive system—stomach cancer	0.000176	0.115	CbGeAlD
Riluzole—SLC7A11—endocrine gland—stomach cancer	0.000146	0.0948	CbGeAlD
Riluzole—Dyspepsia—Docetaxel—stomach cancer	0.000127	0.000319	CcSEcCtD
Riluzole—Hepatitis—Doxorubicin—stomach cancer	0.000127	0.000319	CcSEcCtD
Riluzole—Haemorrhage—Doxorubicin—stomach cancer	0.000127	0.000319	CcSEcCtD
Riluzole—Insomnia—Capecitabine—stomach cancer	0.000126	0.000318	CcSEcCtD
Riluzole—Hypoaesthesia—Doxorubicin—stomach cancer	0.000126	0.000317	CcSEcCtD
Riluzole—Rash—Fluorouracil—stomach cancer	0.000126	0.000317	CcSEcCtD
Riluzole—Dermatitis—Fluorouracil—stomach cancer	0.000126	0.000317	CcSEcCtD
Riluzole—Pharyngitis—Doxorubicin—stomach cancer	0.000126	0.000316	CcSEcCtD
Riluzole—Paraesthesia—Capecitabine—stomach cancer	0.000125	0.000315	CcSEcCtD
Riluzole—Decreased appetite—Docetaxel—stomach cancer	0.000125	0.000315	CcSEcCtD
Riluzole—Headache—Fluorouracil—stomach cancer	0.000125	0.000315	CcSEcCtD
Riluzole—Urinary tract disorder—Doxorubicin—stomach cancer	0.000125	0.000315	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—stomach cancer	0.000125	0.000314	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—stomach cancer	0.000125	0.000314	CcSEcCtD
Riluzole—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000124	0.000313	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—stomach cancer	0.000124	0.000313	CcSEcCtD
Riluzole—Dyspnoea—Capecitabine—stomach cancer	0.000124	0.000313	CcSEcCtD
Riluzole—Fatigue—Docetaxel—stomach cancer	0.000124	0.000313	CcSEcCtD
Riluzole—Angiopathy—Epirubicin—stomach cancer	0.000124	0.000312	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—stomach cancer	0.000124	0.000312	CcSEcCtD
Riluzole—Nausea—Irinotecan—stomach cancer	0.000124	0.000312	CcSEcCtD
Riluzole—Immune system disorder—Epirubicin—stomach cancer	0.000124	0.000311	CcSEcCtD
Riluzole—Mediastinal disorder—Epirubicin—stomach cancer	0.000123	0.00031	CcSEcCtD
Riluzole—Pain—Docetaxel—stomach cancer	0.000123	0.00031	CcSEcCtD
Riluzole—Constipation—Docetaxel—stomach cancer	0.000123	0.00031	CcSEcCtD
Riluzole—Back pain—Methotrexate—stomach cancer	0.000123	0.00031	CcSEcCtD
Riluzole—Dyspepsia—Capecitabine—stomach cancer	0.000123	0.000309	CcSEcCtD
Riluzole—Chills—Epirubicin—stomach cancer	0.000123	0.000309	CcSEcCtD
Riluzole—Arrhythmia—Epirubicin—stomach cancer	0.000122	0.000308	CcSEcCtD
Riluzole—Decreased appetite—Capecitabine—stomach cancer	0.000121	0.000305	CcSEcCtD
Riluzole—Alopecia—Epirubicin—stomach cancer	0.000121	0.000304	CcSEcCtD
Riluzole—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00012	0.000303	CcSEcCtD
Riluzole—Fatigue—Capecitabine—stomach cancer	0.00012	0.000303	CcSEcCtD
Riluzole—Mental disorder—Epirubicin—stomach cancer	0.00012	0.000302	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—stomach cancer	0.00012	0.000301	CcSEcCtD
Riluzole—Pain—Capecitabine—stomach cancer	0.000119	0.0003	CcSEcCtD
Riluzole—Constipation—Capecitabine—stomach cancer	0.000119	0.0003	CcSEcCtD
Riluzole—Malnutrition—Epirubicin—stomach cancer	0.000119	0.0003	CcSEcCtD
Riluzole—Feeling abnormal—Docetaxel—stomach cancer	0.000119	0.000299	CcSEcCtD
Riluzole—Nausea—Fluorouracil—stomach cancer	0.000119	0.000299	CcSEcCtD
Riluzole—Eye disorder—Doxorubicin—stomach cancer	0.000118	0.000298	CcSEcCtD
Riluzole—Ill-defined disorder—Methotrexate—stomach cancer	0.000118	0.000297	CcSEcCtD
Riluzole—Gastrointestinal pain—Docetaxel—stomach cancer	0.000118	0.000297	CcSEcCtD
Riluzole—Anaemia—Methotrexate—stomach cancer	0.000118	0.000296	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—stomach cancer	0.000117	0.000296	CcSEcCtD
Riluzole—Flatulence—Epirubicin—stomach cancer	0.000117	0.000295	CcSEcCtD
Riluzole—Tension—Epirubicin—stomach cancer	0.000117	0.000294	CcSEcCtD
Riluzole—Dysgeusia—Epirubicin—stomach cancer	0.000117	0.000294	CcSEcCtD
Riluzole—Nervousness—Epirubicin—stomach cancer	0.000116	0.000291	CcSEcCtD
Riluzole—Back pain—Epirubicin—stomach cancer	0.000115	0.00029	CcSEcCtD
Riluzole—Feeling abnormal—Capecitabine—stomach cancer	0.000115	0.000289	CcSEcCtD
Riluzole—Angiopathy—Doxorubicin—stomach cancer	0.000115	0.000289	CcSEcCtD
Riluzole—Malaise—Methotrexate—stomach cancer	0.000115	0.000289	CcSEcCtD
Riluzole—Muscle spasms—Epirubicin—stomach cancer	0.000115	0.000288	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—stomach cancer	0.000114	0.000288	CcSEcCtD
Riluzole—Vertigo—Methotrexate—stomach cancer	0.000114	0.000288	CcSEcCtD
Riluzole—Gastrointestinal pain—Capecitabine—stomach cancer	0.000114	0.000287	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—stomach cancer	0.000114	0.000287	CcSEcCtD
Riluzole—Abdominal pain—Docetaxel—stomach cancer	0.000114	0.000287	CcSEcCtD
Riluzole—Body temperature increased—Docetaxel—stomach cancer	0.000114	0.000287	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—stomach cancer	0.000114	0.000287	CcSEcCtD
Riluzole—Chills—Doxorubicin—stomach cancer	0.000114	0.000286	CcSEcCtD
Riluzole—Arrhythmia—Doxorubicin—stomach cancer	0.000113	0.000285	CcSEcCtD
Riluzole—Alopecia—Doxorubicin—stomach cancer	0.000112	0.000282	CcSEcCtD
Riluzole—Cough—Methotrexate—stomach cancer	0.000111	0.00028	CcSEcCtD
Riluzole—Mental disorder—Doxorubicin—stomach cancer	0.000111	0.000279	CcSEcCtD
Riluzole—Urticaria—Capecitabine—stomach cancer	0.000111	0.000279	CcSEcCtD
Riluzole—Ill-defined disorder—Epirubicin—stomach cancer	0.000111	0.000278	CcSEcCtD
Riluzole—Body temperature increased—Capecitabine—stomach cancer	0.00011	0.000278	CcSEcCtD
Riluzole—Abdominal pain—Capecitabine—stomach cancer	0.00011	0.000278	CcSEcCtD
Riluzole—Convulsion—Methotrexate—stomach cancer	0.00011	0.000278	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—stomach cancer	0.00011	0.000277	CcSEcCtD
Riluzole—Anaemia—Epirubicin—stomach cancer	0.00011	0.000277	CcSEcCtD
Riluzole—Agitation—Epirubicin—stomach cancer	0.000109	0.000276	CcSEcCtD
Riluzole—Flatulence—Doxorubicin—stomach cancer	0.000109	0.000273	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—stomach cancer	0.000108	0.000273	CcSEcCtD
Riluzole—Myalgia—Methotrexate—stomach cancer	0.000108	0.000273	CcSEcCtD
Riluzole—Chest pain—Methotrexate—stomach cancer	0.000108	0.000273	CcSEcCtD
Riluzole—Tension—Doxorubicin—stomach cancer	0.000108	0.000272	CcSEcCtD
Riluzole—Dysgeusia—Doxorubicin—stomach cancer	0.000108	0.000272	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000108	0.000271	CcSEcCtD
Riluzole—Malaise—Epirubicin—stomach cancer	0.000107	0.00027	CcSEcCtD
Riluzole—Discomfort—Methotrexate—stomach cancer	0.000107	0.000269	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—stomach cancer	0.000107	0.000269	CcSEcCtD
Riluzole—Vertigo—Epirubicin—stomach cancer	0.000107	0.000269	CcSEcCtD
Riluzole—Syncope—Epirubicin—stomach cancer	0.000107	0.000269	CcSEcCtD
Riluzole—Leukopenia—Epirubicin—stomach cancer	0.000107	0.000268	CcSEcCtD
Riluzole—Back pain—Doxorubicin—stomach cancer	0.000107	0.000268	CcSEcCtD
Riluzole—Hypersensitivity—Docetaxel—stomach cancer	0.000106	0.000267	CcSEcCtD
Riluzole—SCN5A—digestive system—stomach cancer	0.000106	0.069	CbGeAlD
Riluzole—Muscle spasms—Doxorubicin—stomach cancer	0.000106	0.000267	CcSEcCtD
Riluzole—Palpitations—Epirubicin—stomach cancer	0.000105	0.000265	CcSEcCtD
Riluzole—Confusional state—Methotrexate—stomach cancer	0.000105	0.000264	CcSEcCtD
Riluzole—Loss of consciousness—Epirubicin—stomach cancer	0.000105	0.000264	CcSEcCtD
Riluzole—Cough—Epirubicin—stomach cancer	0.000104	0.000262	CcSEcCtD
Riluzole—Anaphylactic shock—Methotrexate—stomach cancer	0.000104	0.000261	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—ALB—stomach cancer	0.000103	0.00102	CbGpPWpGaD
Riluzole—Asthenia—Docetaxel—stomach cancer	0.000103	0.00026	CcSEcCtD
Riluzole—Convulsion—Epirubicin—stomach cancer	0.000103	0.00026	CcSEcCtD
Riluzole—Infection—Methotrexate—stomach cancer	0.000103	0.00026	CcSEcCtD
Riluzole—Hypertension—Epirubicin—stomach cancer	0.000103	0.000259	CcSEcCtD
Riluzole—Hypersensitivity—Capecitabine—stomach cancer	0.000103	0.000259	CcSEcCtD
Riluzole—Ill-defined disorder—Doxorubicin—stomach cancer	0.000102	0.000257	CcSEcCtD
Riluzole—Pruritus—Docetaxel—stomach cancer	0.000102	0.000257	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—stomach cancer	0.000102	0.001	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	0.000102	0.001	CbGpPWpGaD
Riluzole—Nervous system disorder—Methotrexate—stomach cancer	0.000102	0.000256	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—stomach cancer	0.000102	0.000256	CcSEcCtD
Riluzole—Thrombocytopenia—Methotrexate—stomach cancer	0.000102	0.000256	CcSEcCtD
Riluzole—CYP1A2—Phase II conjugation—GSTM1—stomach cancer	0.000102	0.001	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTP1—stomach cancer	0.000101	0.000999	CbGpPWpGaD
Riluzole—Arthralgia—Epirubicin—stomach cancer	0.000101	0.000255	CcSEcCtD
Riluzole—Chest pain—Epirubicin—stomach cancer	0.000101	0.000255	CcSEcCtD
Riluzole—Myalgia—Epirubicin—stomach cancer	0.000101	0.000255	CcSEcCtD
Riluzole—Agitation—Doxorubicin—stomach cancer	0.000101	0.000255	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	0.000101	0.000995	CbGpPWpGaD
Riluzole—Anxiety—Epirubicin—stomach cancer	0.000101	0.000254	CcSEcCtD
Riluzole—Skin disorder—Methotrexate—stomach cancer	0.000101	0.000254	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000101	0.000253	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—stomach cancer	0.0001	0.000253	CcSEcCtD
Riluzole—Discomfort—Epirubicin—stomach cancer	0.0001	0.000252	CcSEcCtD
Riluzole—Asthenia—Capecitabine—stomach cancer	0.0001	0.000252	CcSEcCtD
Riluzole—CYP1A1—Metapathway biotransformation—GSTP1—stomach cancer	0.0001	0.000985	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—RHOA—stomach cancer	9.99e-05	0.000984	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—SMAD4—stomach cancer	9.98e-05	0.000983	CbGpPWpGaD
Riluzole—Malaise—Doxorubicin—stomach cancer	9.94e-05	0.00025	CcSEcCtD
Riluzole—Dry mouth—Epirubicin—stomach cancer	9.92e-05	0.00025	CcSEcCtD
Riluzole—Vertigo—Doxorubicin—stomach cancer	9.9e-05	0.000249	CcSEcCtD
Riluzole—Anorexia—Methotrexate—stomach cancer	9.9e-05	0.000249	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—NOS3—stomach cancer	9.89e-05	0.000973	CbGpPWpGaD
Riluzole—Syncope—Doxorubicin—stomach cancer	9.88e-05	0.000249	CcSEcCtD
Riluzole—Pruritus—Capecitabine—stomach cancer	9.87e-05	0.000248	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—stomach cancer	9.86e-05	0.000248	CcSEcCtD
Riluzole—Diarrhoea—Docetaxel—stomach cancer	9.86e-05	0.000248	CcSEcCtD
Riluzole—Confusional state—Epirubicin—stomach cancer	9.8e-05	0.000247	CcSEcCtD
Riluzole—ABCG2—Metabolism—NDUFS1—stomach cancer	9.77e-05	0.000961	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NDUFV1—stomach cancer	9.77e-05	0.000961	CbGpPWpGaD
Riluzole—Palpitations—Doxorubicin—stomach cancer	9.74e-05	0.000245	CcSEcCtD
Riluzole—Oedema—Epirubicin—stomach cancer	9.72e-05	0.000245	CcSEcCtD
Riluzole—Anaphylactic shock—Epirubicin—stomach cancer	9.72e-05	0.000245	CcSEcCtD
Riluzole—Hypotension—Methotrexate—stomach cancer	9.71e-05	0.000244	CcSEcCtD
Riluzole—Loss of consciousness—Doxorubicin—stomach cancer	9.69e-05	0.000244	CcSEcCtD
Riluzole—Infection—Epirubicin—stomach cancer	9.66e-05	0.000243	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—stomach cancer	9.63e-05	0.000948	CbGpPWpGaD
Riluzole—Cough—Doxorubicin—stomach cancer	9.62e-05	0.000242	CcSEcCtD
Riluzole—Shock—Epirubicin—stomach cancer	9.56e-05	0.000241	CcSEcCtD
Riluzole—CYP1A1—PPARA activates gene expression—PPARG—stomach cancer	9.56e-05	0.000941	CbGpPWpGaD
Riluzole—Convulsion—Doxorubicin—stomach cancer	9.55e-05	0.00024	CcSEcCtD
Riluzole—Diarrhoea—Capecitabine—stomach cancer	9.55e-05	0.00024	CcSEcCtD
Riluzole—Nervous system disorder—Epirubicin—stomach cancer	9.53e-05	0.00024	CcSEcCtD
Riluzole—Dizziness—Docetaxel—stomach cancer	9.53e-05	0.00024	CcSEcCtD
Riluzole—Thrombocytopenia—Epirubicin—stomach cancer	9.52e-05	0.00024	CcSEcCtD
Riluzole—Hypertension—Doxorubicin—stomach cancer	9.51e-05	0.00024	CcSEcCtD
Riluzole—Tachycardia—Epirubicin—stomach cancer	9.49e-05	0.000239	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—FYN—stomach cancer	9.48e-05	0.000933	CbGpPWpGaD
Riluzole—Musculoskeletal discomfort—Methotrexate—stomach cancer	9.46e-05	0.000238	CcSEcCtD
Riluzole—Skin disorder—Epirubicin—stomach cancer	9.44e-05	0.000238	CcSEcCtD
Riluzole—Hyperhidrosis—Epirubicin—stomach cancer	9.4e-05	0.000237	CcSEcCtD
Riluzole—Insomnia—Methotrexate—stomach cancer	9.39e-05	0.000236	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—stomach cancer	9.38e-05	0.000236	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—stomach cancer	9.38e-05	0.000236	CcSEcCtD
Riluzole—Myalgia—Doxorubicin—stomach cancer	9.38e-05	0.000236	CcSEcCtD
Riluzole—SCN5A—Axon guidance—IL6R—stomach cancer	9.36e-05	0.000922	CbGpPWpGaD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—stomach cancer	9.35e-05	0.000921	CbGpPWpGaD
Riluzole—Anxiety—Doxorubicin—stomach cancer	9.35e-05	0.000235	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTT1—stomach cancer	9.34e-05	0.000919	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTM1—stomach cancer	9.33e-05	0.000918	CbGpPWpGaD
Riluzole—Paraesthesia—Methotrexate—stomach cancer	9.33e-05	0.000235	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	9.32e-05	0.000235	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TNF—stomach cancer	9.28e-05	0.000913	CbGpPWpGaD
Riluzole—Discomfort—Doxorubicin—stomach cancer	9.27e-05	0.000233	CcSEcCtD
Riluzole—Anorexia—Epirubicin—stomach cancer	9.27e-05	0.000233	CcSEcCtD
Riluzole—Dyspnoea—Methotrexate—stomach cancer	9.26e-05	0.000233	CcSEcCtD
Riluzole—Somnolence—Methotrexate—stomach cancer	9.23e-05	0.000232	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—CYP2A6—stomach cancer	9.23e-05	0.000908	CbGpPWpGaD
Riluzole—Dizziness—Capecitabine—stomach cancer	9.23e-05	0.000232	CcSEcCtD
Riluzole—CYP1A1—Metapathway biotransformation—GSTM1—stomach cancer	9.2e-05	0.000905	CbGpPWpGaD
Riluzole—Dry mouth—Doxorubicin—stomach cancer	9.18e-05	0.000231	CcSEcCtD
Riluzole—Vomiting—Docetaxel—stomach cancer	9.16e-05	0.000231	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—stomach cancer	9.14e-05	0.00023	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	9.12e-05	0.000898	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	9.12e-05	0.000898	CbGpPWpGaD
Riluzole—Rash—Docetaxel—stomach cancer	9.09e-05	0.000229	CcSEcCtD
Riluzole—Hypotension—Epirubicin—stomach cancer	9.08e-05	0.000229	CcSEcCtD
Riluzole—Dermatitis—Docetaxel—stomach cancer	9.08e-05	0.000229	CcSEcCtD
Riluzole—Confusional state—Doxorubicin—stomach cancer	9.07e-05	0.000228	CcSEcCtD
Riluzole—Decreased appetite—Methotrexate—stomach cancer	9.03e-05	0.000227	CcSEcCtD
Riluzole—Headache—Docetaxel—stomach cancer	9.03e-05	0.000227	CcSEcCtD
Riluzole—CYP1A2—Arachidonic acid metabolism—PTGS2—stomach cancer	9.01e-05	0.000887	CbGpPWpGaD
Riluzole—Anaphylactic shock—Doxorubicin—stomach cancer	8.99e-05	0.000226	CcSEcCtD
Riluzole—Oedema—Doxorubicin—stomach cancer	8.99e-05	0.000226	CcSEcCtD
Riluzole—Gastrointestinal disorder—Methotrexate—stomach cancer	8.97e-05	0.000226	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	8.96e-05	0.000882	CbGpPWpGaD
Riluzole—Fatigue—Methotrexate—stomach cancer	8.95e-05	0.000225	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—ALB—stomach cancer	8.95e-05	0.000881	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP2—stomach cancer	8.94e-05	0.000879	CbGpPWpGaD
Riluzole—Infection—Doxorubicin—stomach cancer	8.93e-05	0.000225	CcSEcCtD
Riluzole—Pain—Methotrexate—stomach cancer	8.88e-05	0.000224	CcSEcCtD
Riluzole—Vomiting—Capecitabine—stomach cancer	8.87e-05	0.000223	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Epirubicin—stomach cancer	8.86e-05	0.000223	CcSEcCtD
Riluzole—CYP1A2—Metapathway biotransformation—AKR1C3—stomach cancer	8.85e-05	0.000871	CbGpPWpGaD
Riluzole—Shock—Doxorubicin—stomach cancer	8.85e-05	0.000223	CcSEcCtD
Riluzole—Nervous system disorder—Doxorubicin—stomach cancer	8.82e-05	0.000222	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—stomach cancer	8.81e-05	0.000222	CcSEcCtD
Riluzole—Rash—Capecitabine—stomach cancer	8.8e-05	0.000221	CcSEcCtD
Riluzole—Insomnia—Epirubicin—stomach cancer	8.79e-05	0.000221	CcSEcCtD
Riluzole—Dermatitis—Capecitabine—stomach cancer	8.79e-05	0.000221	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—stomach cancer	8.78e-05	0.000221	CcSEcCtD
Riluzole—Headache—Capecitabine—stomach cancer	8.74e-05	0.00022	CcSEcCtD
Riluzole—Skin disorder—Doxorubicin—stomach cancer	8.74e-05	0.00022	CcSEcCtD
Riluzole—Paraesthesia—Epirubicin—stomach cancer	8.73e-05	0.00022	CcSEcCtD
Riluzole—CYP1A1—Metabolism—ACAD8—stomach cancer	8.73e-05	0.000859	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—BLVRB—stomach cancer	8.71e-05	0.000857	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PGLS—stomach cancer	8.71e-05	0.000857	CbGpPWpGaD
Riluzole—Hyperhidrosis—Doxorubicin—stomach cancer	8.69e-05	0.000219	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	8.68e-05	0.000854	CbGpPWpGaD
Riluzole—Dyspnoea—Epirubicin—stomach cancer	8.67e-05	0.000218	CcSEcCtD
Riluzole—Somnolence—Epirubicin—stomach cancer	8.64e-05	0.000218	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	8.6e-05	0.000846	CbGpPWpGaD
Riluzole—Anorexia—Doxorubicin—stomach cancer	8.57e-05	0.000216	CcSEcCtD
Riluzole—Nausea—Docetaxel—stomach cancer	8.56e-05	0.000215	CcSEcCtD
Riluzole—Feeling abnormal—Methotrexate—stomach cancer	8.56e-05	0.000215	CcSEcCtD
Riluzole—Dyspepsia—Epirubicin—stomach cancer	8.56e-05	0.000215	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	8.53e-05	0.000839	CbGpPWpGaD
Riluzole—Gastrointestinal pain—Methotrexate—stomach cancer	8.49e-05	0.000214	CcSEcCtD
Riluzole—SCN5A—Axon guidance—RHOA—stomach cancer	8.46e-05	0.000832	CbGpPWpGaD
Riluzole—Decreased appetite—Epirubicin—stomach cancer	8.45e-05	0.000213	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	8.42e-05	0.000828	CbGpPWpGaD
Riluzole—Hypotension—Doxorubicin—stomach cancer	8.4e-05	0.000212	CcSEcCtD
Riluzole—Gastrointestinal disorder—Epirubicin—stomach cancer	8.39e-05	0.000211	CcSEcCtD
Riluzole—Fatigue—Epirubicin—stomach cancer	8.38e-05	0.000211	CcSEcCtD
Riluzole—Pain—Epirubicin—stomach cancer	8.31e-05	0.000209	CcSEcCtD
Riluzole—Constipation—Epirubicin—stomach cancer	8.31e-05	0.000209	CcSEcCtD
Riluzole—ABCG2—Metabolism—PPAP2A—stomach cancer	8.31e-05	0.000817	CbGpPWpGaD
Riluzole—Nausea—Capecitabine—stomach cancer	8.29e-05	0.000209	CcSEcCtD
Riluzole—Urticaria—Methotrexate—stomach cancer	8.25e-05	0.000208	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—stomach cancer	8.21e-05	0.000207	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—stomach cancer	8.21e-05	0.000207	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Doxorubicin—stomach cancer	8.19e-05	0.000206	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—stomach cancer	8.13e-05	0.000205	CcSEcCtD
Riluzole—Paraesthesia—Doxorubicin—stomach cancer	8.08e-05	0.000203	CcSEcCtD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	8.05e-05	0.000792	CbGpPWpGaD
Riluzole—CYP1A2—hematopoietic system—stomach cancer	8.03e-05	0.0523	CbGeAlD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	8.02e-05	0.000789	CbGpPWpGaD
Riluzole—Dyspnoea—Doxorubicin—stomach cancer	8.02e-05	0.000202	CcSEcCtD
Riluzole—Feeling abnormal—Epirubicin—stomach cancer	8.01e-05	0.000202	CcSEcCtD
Riluzole—Somnolence—Doxorubicin—stomach cancer	8e-05	0.000201	CcSEcCtD
Riluzole—Gastrointestinal pain—Epirubicin—stomach cancer	7.95e-05	0.0002	CcSEcCtD
Riluzole—CYP1A1—hematopoietic system—stomach cancer	7.92e-05	0.0516	CbGeAlD
Riluzole—Dyspepsia—Doxorubicin—stomach cancer	7.92e-05	0.000199	CcSEcCtD
Riluzole—SCN5A—Axon guidance—ERBB2—stomach cancer	7.83e-05	0.000771	CbGpPWpGaD
Riluzole—Decreased appetite—Doxorubicin—stomach cancer	7.82e-05	0.000197	CcSEcCtD
Riluzole—CYP1A1—Metabolism—GMPR2—stomach cancer	7.78e-05	0.000765	CbGpPWpGaD
Riluzole—Gastrointestinal disorder—Doxorubicin—stomach cancer	7.76e-05	0.000195	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—stomach cancer	7.75e-05	0.000195	CcSEcCtD
Riluzole—Urticaria—Epirubicin—stomach cancer	7.72e-05	0.000194	CcSEcCtD
Riluzole—Pain—Doxorubicin—stomach cancer	7.69e-05	0.000194	CcSEcCtD
Riluzole—Constipation—Doxorubicin—stomach cancer	7.69e-05	0.000194	CcSEcCtD
Riluzole—Abdominal pain—Epirubicin—stomach cancer	7.68e-05	0.000193	CcSEcCtD
Riluzole—Body temperature increased—Epirubicin—stomach cancer	7.68e-05	0.000193	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—stomach cancer	7.65e-05	0.000193	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—MET—stomach cancer	7.65e-05	0.000752	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CDK4—stomach cancer	7.65e-05	0.000752	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	7.58e-05	0.000746	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	7.51e-05	0.000739	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6ST—stomach cancer	7.49e-05	0.000737	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL6—stomach cancer	7.49e-05	0.000737	CbGpPWpGaD
Riluzole—Asthenia—Methotrexate—stomach cancer	7.45e-05	0.000188	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	7.42e-05	0.00073	CbGpPWpGaD
Riluzole—Feeling abnormal—Doxorubicin—stomach cancer	7.41e-05	0.000187	CcSEcCtD
Riluzole—ABCG2—Metabolism—CKB—stomach cancer	7.4e-05	0.000729	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NDUFA2—stomach cancer	7.4e-05	0.000729	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—FBP1—stomach cancer	7.4e-05	0.000729	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CA1—stomach cancer	7.4e-05	0.000729	CbGpPWpGaD
Riluzole—Gastrointestinal pain—Doxorubicin—stomach cancer	7.35e-05	0.000185	CcSEcCtD
Riluzole—Pruritus—Methotrexate—stomach cancer	7.35e-05	0.000185	CcSEcCtD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—stomach cancer	7.31e-05	0.00072	CbGpPWpGaD
Riluzole—CYP1A1—epithelium—stomach cancer	7.24e-05	0.0471	CbGeAlD
Riluzole—Hypersensitivity—Epirubicin—stomach cancer	7.16e-05	0.00018	CcSEcCtD
Riluzole—Urticaria—Doxorubicin—stomach cancer	7.14e-05	0.00018	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—VEGFA—stomach cancer	7.13e-05	0.000701	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—IDH3B—stomach cancer	7.11e-05	0.0007	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SUCLG1—stomach cancer	7.11e-05	0.0007	CbGpPWpGaD
Riluzole—Abdominal pain—Doxorubicin—stomach cancer	7.11e-05	0.000179	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—stomach cancer	7.11e-05	0.000179	CcSEcCtD
Riluzole—Diarrhoea—Methotrexate—stomach cancer	7.11e-05	0.000179	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	6.98e-05	0.000687	CbGpPWpGaD
Riluzole—Asthenia—Epirubicin—stomach cancer	6.97e-05	0.000176	CcSEcCtD
Riluzole—ABCG2—Metabolism—PLIN2—stomach cancer	6.96e-05	0.000685	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PPARG—stomach cancer	6.95e-05	0.000684	CbGpPWpGaD
Riluzole—Pruritus—Epirubicin—stomach cancer	6.88e-05	0.000173	CcSEcCtD
Riluzole—Dizziness—Methotrexate—stomach cancer	6.87e-05	0.000173	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	6.83e-05	0.000672	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	6.83e-05	0.000672	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	6.83e-05	0.000672	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CA2—stomach cancer	6.77e-05	0.000666	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	6.75e-05	0.000664	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—MAPK3—stomach cancer	6.74e-05	0.000663	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP9—stomach cancer	6.72e-05	0.000661	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6R—stomach cancer	6.68e-05	0.000658	CbGpPWpGaD
Riluzole—Diarrhoea—Epirubicin—stomach cancer	6.65e-05	0.000167	CcSEcCtD
Riluzole—Hypersensitivity—Doxorubicin—stomach cancer	6.63e-05	0.000167	CcSEcCtD
Riluzole—CYP1A1—Metabolism—NDUFV1—stomach cancer	6.61e-05	0.000651	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NDUFS1—stomach cancer	6.61e-05	0.000651	CbGpPWpGaD
Riluzole—Vomiting—Methotrexate—stomach cancer	6.6e-05	0.000166	CcSEcCtD
Riluzole—ABCG2—Metabolism—PGAM1—stomach cancer	6.6e-05	0.000649	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NT5E—stomach cancer	6.6e-05	0.000649	CbGpPWpGaD
Riluzole—Rash—Methotrexate—stomach cancer	6.55e-05	0.000165	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—stomach cancer	6.54e-05	0.000165	CcSEcCtD
Riluzole—Headache—Methotrexate—stomach cancer	6.51e-05	0.000164	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	6.5e-05	0.00064	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	6.5e-05	0.00064	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTP1—stomach cancer	6.47e-05	0.000637	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	6.46e-05	0.000636	CbGpPWpGaD
Riluzole—Asthenia—Doxorubicin—stomach cancer	6.45e-05	0.000162	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	6.45e-05	0.000635	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—stomach cancer	6.45e-05	0.000634	CbGpPWpGaD
Riluzole—Dizziness—Epirubicin—stomach cancer	6.43e-05	0.000162	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—MAPK1—stomach cancer	6.41e-05	0.000631	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	6.38e-05	0.000628	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP2—stomach cancer	6.38e-05	0.000628	CbGpPWpGaD
Riluzole—Pruritus—Doxorubicin—stomach cancer	6.36e-05	0.00016	CcSEcCtD
Riluzole—ABCG2—Metabolism—ALDH7A1—stomach cancer	6.3e-05	0.00062	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PLCE1—stomach cancer	6.3e-05	0.00062	CbGpPWpGaD
Riluzole—Vomiting—Epirubicin—stomach cancer	6.18e-05	0.000156	CcSEcCtD
Riluzole—Nausea—Methotrexate—stomach cancer	6.17e-05	0.000155	CcSEcCtD
Riluzole—Diarrhoea—Doxorubicin—stomach cancer	6.15e-05	0.000155	CcSEcCtD
Riluzole—Rash—Epirubicin—stomach cancer	6.13e-05	0.000154	CcSEcCtD
Riluzole—Dermatitis—Epirubicin—stomach cancer	6.12e-05	0.000154	CcSEcCtD
Riluzole—Headache—Epirubicin—stomach cancer	6.09e-05	0.000153	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—KRAS—stomach cancer	6.06e-05	0.000596	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—RHOA—stomach cancer	6.04e-05	0.000594	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—UMPS—stomach cancer	6.04e-05	0.000594	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—stomach cancer	6.03e-05	0.000594	CbGpPWpGaD
Riluzole—Dizziness—Doxorubicin—stomach cancer	5.95e-05	0.00015	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTM1—stomach cancer	5.95e-05	0.000585	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—BLVRB—stomach cancer	5.89e-05	0.00058	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PGLS—stomach cancer	5.89e-05	0.00058	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	5.87e-05	0.000577	CbGpPWpGaD
Riluzole—Nausea—Epirubicin—stomach cancer	5.77e-05	0.000145	CcSEcCtD
Riluzole—Vomiting—Doxorubicin—stomach cancer	5.72e-05	0.000144	CcSEcCtD
Riluzole—SCN5A—Axon guidance—MAPK3—stomach cancer	5.71e-05	0.000562	CbGpPWpGaD
Riluzole—Rash—Doxorubicin—stomach cancer	5.67e-05	0.000143	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—stomach cancer	5.67e-05	0.000143	CcSEcCtD
Riluzole—Headache—Doxorubicin—stomach cancer	5.63e-05	0.000142	CcSEcCtD
Riluzole—CYP1A1—Metabolism—PPAP2A—stomach cancer	5.62e-05	0.000553	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PDHA1—stomach cancer	5.61e-05	0.000552	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ECHS1—stomach cancer	5.61e-05	0.000552	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ERBB2—stomach cancer	5.59e-05	0.00055	CbGpPWpGaD
Riluzole—CYP1A2—digestive system—stomach cancer	5.59e-05	0.0363	CbGeAlD
Riluzole—SLC7A11—Hemostasis—PIK3CA—stomach cancer	5.57e-05	0.000548	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ACAD8—stomach cancer	5.56e-05	0.000548	CbGpPWpGaD
Riluzole—CYP1A1—digestive system—stomach cancer	5.51e-05	0.0359	CbGeAlD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	5.48e-05	0.000539	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	5.44e-05	0.000535	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MAPK1—stomach cancer	5.43e-05	0.000534	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—EGFR—stomach cancer	5.43e-05	0.000534	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	5.41e-05	0.000532	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—HMOX1—stomach cancer	5.4e-05	0.000531	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—stomach cancer	5.38e-05	0.00053	CbGpPWpGaD
Riluzole—ABCG2—bone marrow—stomach cancer	5.35e-05	0.0348	CbGeAlD
Riluzole—Nausea—Doxorubicin—stomach cancer	5.34e-05	0.000134	CcSEcCtD
Riluzole—ABCG2—Metabolism—TYMP—stomach cancer	5.28e-05	0.000519	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—FADS1—stomach cancer	5.28e-05	0.000519	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—HRAS—stomach cancer	5.15e-05	0.000507	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—KRAS—stomach cancer	5.13e-05	0.000505	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	5.11e-05	0.000503	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CKB—stomach cancer	5.01e-05	0.000493	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NDUFA2—stomach cancer	5.01e-05	0.000493	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CA1—stomach cancer	5.01e-05	0.000493	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—FBP1—stomach cancer	5.01e-05	0.000493	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GMPR2—stomach cancer	4.96e-05	0.000488	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SREBF2—stomach cancer	4.94e-05	0.000486	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—RORA—stomach cancer	4.88e-05	0.00048	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP9—stomach cancer	4.79e-05	0.000472	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	4.79e-05	0.000471	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	4.73e-05	0.000466	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PLIN2—stomach cancer	4.71e-05	0.000464	CbGpPWpGaD
Riluzole—CYP1A2—endocrine gland—stomach cancer	4.62e-05	0.03	CbGeAlD
Riluzole—CYP1A1—Metabolism—CA2—stomach cancer	4.58e-05	0.000451	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALDOB—stomach cancer	4.57e-05	0.00045	CbGpPWpGaD
Riluzole—CYP1A1—endocrine gland—stomach cancer	4.55e-05	0.0296	CbGeAlD
Riluzole—CYP1A2—Metabolism—SUCLG1—stomach cancer	4.54e-05	0.000446	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—IDH3B—stomach cancer	4.54e-05	0.000446	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NT5E—stomach cancer	4.47e-05	0.00044	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PGAM1—stomach cancer	4.47e-05	0.00044	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—HRAS—stomach cancer	4.36e-05	0.000429	CbGpPWpGaD
Riluzole—ABCG2—liver—stomach cancer	4.32e-05	0.0281	CbGeAlD
Riluzole—SCN5A—Developmental Biology—VEGFA—stomach cancer	4.3e-05	0.000424	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—STAT3—stomach cancer	4.26e-05	0.000419	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PLCE1—stomach cancer	4.26e-05	0.000419	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALDH7A1—stomach cancer	4.26e-05	0.000419	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALOX5—stomach cancer	4.25e-05	0.000418	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NDUFV1—stomach cancer	4.22e-05	0.000415	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NDUFS1—stomach cancer	4.22e-05	0.000415	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—DPYD—stomach cancer	4.18e-05	0.000412	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—IL6—stomach cancer	4.17e-05	0.000411	CbGpPWpGaD
Riluzole—CYP1A2—liver—stomach cancer	4.16e-05	0.0271	CbGeAlD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	4.12e-05	0.000406	CbGpPWpGaD
Riluzole—CYP1A1—liver—stomach cancer	4.1e-05	0.0267	CbGeAlD
Riluzole—ABCG2—Transmembrane transport of small molecules—APOA1—stomach cancer	4.09e-05	0.000403	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—UMPS—stomach cancer	4.09e-05	0.000402	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MAPK3—stomach cancer	4.07e-05	0.000401	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MAPK1—stomach cancer	3.87e-05	0.000381	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EGFR—stomach cancer	3.87e-05	0.000381	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PDHA1—stomach cancer	3.8e-05	0.000374	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ECHS1—stomach cancer	3.8e-05	0.000374	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BLVRB—stomach cancer	3.76e-05	0.00037	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PGLS—stomach cancer	3.76e-05	0.00037	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTT1—stomach cancer	3.7e-05	0.000364	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TNF—stomach cancer	3.69e-05	0.000363	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—KRAS—stomach cancer	3.66e-05	0.00036	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2A6—stomach cancer	3.66e-05	0.00036	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPAP2A—stomach cancer	3.59e-05	0.000353	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TYMP—stomach cancer	3.57e-05	0.000351	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—FADS1—stomach cancer	3.57e-05	0.000351	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKR1C3—stomach cancer	3.56e-05	0.00035	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ENO1—stomach cancer	3.47e-05	0.000341	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	3.45e-05	0.000339	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SREBF2—stomach cancer	3.34e-05	0.000329	CbGpPWpGaD
Riluzole—ABCG2—lymph node—stomach cancer	3.32e-05	0.0216	CbGeAlD
Riluzole—CYP1A1—Metabolism—RORA—stomach cancer	3.3e-05	0.000325	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ALB—stomach cancer	3.24e-05	0.000319	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NDUFA2—stomach cancer	3.2e-05	0.000314	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—FBP1—stomach cancer	3.2e-05	0.000314	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CKB—stomach cancer	3.2e-05	0.000314	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CA1—stomach cancer	3.2e-05	0.000314	CbGpPWpGaD
Riluzole—CYP1A1—lymph node—stomach cancer	3.15e-05	0.0205	CbGeAlD
Riluzole—SCN5A—Developmental Biology—HRAS—stomach cancer	3.11e-05	0.000306	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALDOB—stomach cancer	3.1e-05	0.000305	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CD44—stomach cancer	3.07e-05	0.000303	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PLIN2—stomach cancer	3e-05	0.000296	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6—stomach cancer	2.98e-05	0.000293	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CA2—stomach cancer	2.92e-05	0.000288	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.92e-05	0.000287	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.91e-05	0.000287	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALOX5—stomach cancer	2.88e-05	0.000283	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PGAM1—stomach cancer	2.85e-05	0.00028	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NT5E—stomach cancer	2.85e-05	0.00028	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—DPYD—stomach cancer	2.83e-05	0.000279	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PLCE1—stomach cancer	2.72e-05	0.000267	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALDH7A1—stomach cancer	2.72e-05	0.000267	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPP2R1A—stomach cancer	2.61e-05	0.000257	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—UMPS—stomach cancer	2.6e-05	0.000256	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.57e-05	0.000253	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTP1—stomach cancer	2.56e-05	0.000252	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HMOX1—stomach cancer	2.53e-05	0.000249	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTT1—stomach cancer	2.5e-05	0.000246	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2A6—stomach cancer	2.48e-05	0.000244	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PDHA1—stomach cancer	2.42e-05	0.000238	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ECHS1—stomach cancer	2.42e-05	0.000238	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKR1C3—stomach cancer	2.41e-05	0.000237	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TYMS—stomach cancer	2.38e-05	0.000235	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTM1—stomach cancer	2.36e-05	0.000232	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ENO1—stomach cancer	2.35e-05	0.000231	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.31e-05	0.000227	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TYMP—stomach cancer	2.28e-05	0.000224	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—FADS1—stomach cancer	2.28e-05	0.000224	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ERCC2—stomach cancer	2.22e-05	0.000218	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SREBF2—stomach cancer	2.13e-05	0.00021	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—RORA—stomach cancer	2.11e-05	0.000207	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MTHFR—stomach cancer	2.08e-05	0.000205	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CD44—stomach cancer	2.08e-05	0.000205	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.02e-05	0.000199	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALDOB—stomach cancer	1.97e-05	0.000194	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CAV1—stomach cancer	1.92e-05	0.000189	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOA1—stomach cancer	1.92e-05	0.000189	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.86e-05	0.000183	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.86e-05	0.000183	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALOX5—stomach cancer	1.84e-05	0.000181	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—DPYD—stomach cancer	1.81e-05	0.000178	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPP2R1A—stomach cancer	1.77e-05	0.000174	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTP1—stomach cancer	1.74e-05	0.000171	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HMOX1—stomach cancer	1.71e-05	0.000168	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPARG—stomach cancer	1.69e-05	0.000166	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.64e-05	0.000161	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TYMS—stomach cancer	1.61e-05	0.000159	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTT1—stomach cancer	1.6e-05	0.000157	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTM1—stomach cancer	1.59e-05	0.000157	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2A6—stomach cancer	1.58e-05	0.000155	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.54e-05	0.000151	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALB—stomach cancer	1.52e-05	0.000149	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ERCC2—stomach cancer	1.5e-05	0.000148	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ENO1—stomach cancer	1.5e-05	0.000147	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.47e-05	0.000145	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NOS3—stomach cancer	1.45e-05	0.000143	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MTHFR—stomach cancer	1.41e-05	0.000139	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—stomach cancer	1.33e-05	0.000131	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CD44—stomach cancer	1.33e-05	0.000131	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CAV1—stomach cancer	1.3e-05	0.000128	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOA1—stomach cancer	1.3e-05	0.000128	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.29e-05	0.000127	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.24e-05	0.000122	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPARG—stomach cancer	1.14e-05	0.000112	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.13e-05	0.000111	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTP1—stomach cancer	1.11e-05	0.000109	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HMOX1—stomach cancer	1.09e-05	0.000107	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TYMS—stomach cancer	1.03e-05	0.000101	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALB—stomach cancer	1.03e-05	0.000101	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTM1—stomach cancer	1.02e-05	0.0001	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NOS3—stomach cancer	9.83e-06	9.68e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ERCC2—stomach cancer	9.56e-06	9.41e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—stomach cancer	8.99e-06	8.85e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MTHFR—stomach cancer	8.99e-06	8.85e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CAV1—stomach cancer	8.29e-06	8.16e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOA1—stomach cancer	8.27e-06	8.14e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CA—stomach cancer	8.17e-06	8.04e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.92e-06	7.79e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPARG—stomach cancer	7.29e-06	7.17e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALB—stomach cancer	6.55e-06	6.45e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NOS3—stomach cancer	6.27e-06	6.17e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—stomach cancer	5.73e-06	5.64e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CA—stomach cancer	5.53e-06	5.44e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CA—stomach cancer	3.53e-06	3.47e-05	CbGpPWpGaD
